Terry Horgan, the patient who was undergoing gene editing treatment being conducted by Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try and save him from the fatal condition, died during the landmark Crispr study.
In an experiment led by GSU using gene editing, the team removed the vasopressin receptor, a hormone that controls aggression in hamsters, which unexpectedly turned them into hyper-aggressive bullies.